X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Indoco Remedies with India Infoline - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

INDOCO REMEDIES vs IIFL HOLDINGS - Comparison Results

INDOCO REMEDIES    Change

Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More

IIFL HOLDINGS 
   Change

India Infoline is one of the oldest and leading players in the Indian broking services space. Besides offering the entire gamut of financial services covering investment products ranging from equities and derivatives, commodities and portfolio manage... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    INDOCO REMEDIES IIFL HOLDINGS INDOCO REMEDIES/
IIFL HOLDINGS
 
P/E (TTM) x 22.8 22.8 100.1% View Chart
P/BV x 2.7 6.2 43.6% View Chart
Dividend Yield % 0.8 0.7 114.9%  

Financials

 INDOCO REMEDIES   IIFL HOLDINGS
EQUITY SHARE DATA
    INDOCO REMEDIES
Mar-17
IIFL HOLDINGS
Mar-16
INDOCO REMEDIES/
IIFL HOLDINGS
5-Yr Chart
Click to enlarge
High Rs360226 159.8%   
Low Rs249160 155.5%   
Sales per share (Unadj.) Rs119.0125.9 94.6%  
Earnings per share (Unadj.) Rs8.416.1 51.8%  
Cash flow per share (Unadj.) Rs15.218.2 83.5%  
Dividends per share (Unadj.) Rs1.604.25 37.6%  
Dividend yield (eoy) %0.52.2 23.8%  
Book value per share (Unadj.) Rs70.792.2 76.6%  
Shares outstanding (eoy) m92.15316.54 29.1%   
Bonus/Rights/Conversions -ESOP-  
Price / Sales ratio x2.61.5 167.1%   
Avg P/E ratio x36.411.9 305.0%  
P/CF ratio (eoy) x20.010.6 189.2%  
Price / Book Value ratio x4.32.1 206.1%  
Dividend payout %19.126.3 72.7%   
Avg Mkt Cap Rs m28,08361,061 46.0%   
No. of employees `0006.0NA-   
Total wages/salary Rs m2,1677,045 30.8%   
Avg. sales/employee Rs Th1,817.0NM-  
Avg. wages/employee Rs Th359.0NM-  
Avg. net profit/employee Rs Th127.7NM-  
INCOME DATA
Net Sales Rs m10,96839,840 27.5%  
Other income Rs m40116 34.2%   
Total revenues Rs m11,00739,957 27.5%   
Gross profit Rs m1,56525,771 6.1%  
Depreciation Rs m633661 95.8%   
Interest Rs m6216,800 0.4%   
Profit before tax Rs m9098,426 10.8%   
Minority Interest Rs m0-436 0.0%   
Prior Period Items Rs m0-42 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1392,836 4.9%   
Profit after tax Rs m7715,112 15.1%  
Gross profit margin %14.364.7 22.1%  
Effective tax rate %15.333.7 45.3%   
Net profit margin %7.012.8 54.8%  
BALANCE SHEET DATA
Current assets Rs m5,725122,903 4.7%   
Current liabilities Rs m5,45496,534 5.6%   
Net working cap to sales %2.566.2 3.7%  
Current ratio x1.01.3 82.4%  
Inventory Days Days623 2,039.3%  
Debtors Days Days7254 133.7%  
Net fixed assets Rs m5,3074,805 110.5%   
Share capital Rs m184633 29.1%   
"Free" reserves Rs m6,33120,773 30.5%   
Net worth Rs m6,51629,200 22.3%   
Long term debt Rs m1,32390,203 1.5%   
Total assets Rs m11,970228,766 5.2%  
Interest coverage x15.61.5 1,041.9%   
Debt to equity ratio x0.23.1 6.6%  
Sales to assets ratio x0.90.2 526.1%   
Return on assets %7.09.6 72.6%  
Return on equity %11.817.5 67.6%  
Return on capital %12.420.7 59.8%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m4,5070-   
Fx outflow Rs m1,1410-   
Net fx Rs m3,3660-   
CASH FLOW
From Operations Rs m886-541 -163.9%  
From Investments Rs m-1,706-6,707 25.4%  
From Financial Activity Rs m1,3165,249 25.1%  
Net Cashflow Rs m497-1,999 -24.8%  

Share Holding

Indian Promoters % 59.2 30.7 192.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 12.5 0.8 1,562.5%  
FIIs % 6.0 44.4 13.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 22.4 24.2 92.6%  
Shareholders   12,805 27,982 45.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare INDOCO REMEDIES With:   FUTURE CONSUMER  MIC ELECTRONICS  NALWA SONS INV  KITEX GARMENTS  TIMKEN INDIA  



Today's Market

Sensex Finishes on a Flat Note; Dr Reddy's & Lupin Surge over 2%(Closing)

Indian share markets continued to trade just above the dotted line in the afternoon session in a lackluster day of trading. At the closing bell, the BSE Sensex closed higher by 33 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Aug 22, 2017 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES - THOMAS COOK INDIA COMPARISON

COMPARE INDOCO REMEDIES WITH

MARKET STATS